Monday, February 17, 2014

Can the Rally in Biotechs Keep Its Momentum?

Can the Rally in Biotechs Keep Its Momentum?



Here is an excellent article about biotech stocks.  You can quickly get ahead or quickly go broke with drug stocks.  It is certainly a good idea to have at least one biotech company or biotech ETF in your portfolio, but it should not involve more than 5% of your money due to the great risk.  I wish I had watched Biogen (BIIB) over the years.  I can remember when it was less than $50 per share, and now it is over $300 per share.






No comments:

Post a Comment